NCT03301207 2019-12-05A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell MalignancyJanssen Research & Development, LLCPhase 1 Completed25 enrolled